PR001236 (Project)

Dcc Asset:

MW submission packet 20260310.zip

Processed File (Entity type)

Dcc:

Metabolomics

DCC (Entity type)

Child Project:

PPR00001

Project (Entity type)

Persistent Id:http://dx.doi.org/10.21228/M8Z10X

Description:Methotrexate (MTX) efficacy in the treatment of rheumatoid arthritis (RA) is variable and unpredictable, resulting in a need to identify biomarkers to guide drug therapy. This study evaluates changes in the plasma metabolome associated with response to MTX in RA with the goal of understanding the metabolic basis for MTX efficacy towards the identification of potential metabolic biomarkers of MTX response.

Results found

Linked to

	Label	Description
	SA183895 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183873 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183900 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183921 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183922 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183898 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183905 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183904 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183890 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	ST001949 AN003173 Results.txt File (Entity type)	A 472 KB file from Metabolomics produced from OBI:0003110 as part of the PR001236 project